|
Toripalimab+Chemotherapy Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Carboplatin, Cisplatin, Docetaxel
Pipeline
Phase 2: 2
Top Sponsors
- Sun Yat-sen University1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Indications
- Cancer2
- HPV 16 Positive Oropharyngeal Tumors (OPC)1
- Sinonasal Squamous Cell Carcinoma1
- HPV (Human Papillomavirus)-Associated Carcinoma1
- Skull Base Tumors1
Other1 trial
Baltimore, Maryland1 trial
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Johns Hopkins Hospital East Baltimore
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.